Home
Global Biopharmaceutical Company - Br...

Global Biopharmaceutical... Market Share Analysis for November 2025

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

Health > Biotechnology and Pharmaceuticals

Domainbmsfrance.fr

Year Founded--

Employees501 - 1000

Annual Revenue--

Global Biopharmaceutical Company - Br...

Global Biopharmaceutical Company - Br... (including company regionals)

bmsfrance.fr

See more website traffic and engagement information

Total visits to Global Biopharmaceutical Company - Br...'s top domains

Understand Global Biopharmaceutical Company - Br... market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Global Biopharmaceutical Company - Br...'s top domains

Analyze Global Biopharmaceutical Company - Br... engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Global Biopharmaceutical Company - Br...'s top domains

See how Global Biopharmaceutical Company - Br... keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Global Biopharmaceutical Company - Br... top competitors by domain

Top similar sites in November 2025, ranked by their affinity

boehringer-ingelheim.frCompany NameBoehringer IngelheimEmployees> 10001HQGermany, Ingelheim am RheinAnnual revenue> $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Global Biopharmaceutical Company - Br...

These are the website technologies, by industry, used by Global Biopharmaceutical Company - Br... top domains

Advertising (7)

DoubleClick

Conversion & Analytics (5)

DoubleClick Floodlight

Social (5)

Instagram

Audio Video Media (2)

YouTube

More Technologies

7

See all

News & Signals from Global Biopharmaceutical Company - Br...

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBmsfrance acquired Myokardia for $13B on Oct 12th '20.Bristol-Myers Squibb said on Monday it would buy MyoKardia for about $13 billion to bolster its portfolio of heart disease treatments, as it seeks to reduce some of its dependence on cancer drugs.

NewsBmsfrance acquired Celgene Corp. for $74B on Jan 1st '19.REUTERS/Regis Duvignau/File Photo New York-based Bristol-Myers bought Celgene for more than $74 billion in a deal announced last January.

NewsDomain Therapeutics SA partnered with Bmsfrance on Feb 27th '18.Domain Therapeutics, a France- and Quebec-based biopharmaceutical company that specializes in the research and development of new drug candidates that target transmembrane receptors, today announces the signing of a licensing agreement for its bioSens-All™ technology with Bristol-Myers Squibb, a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.